Subscribe to RSS

DOI: 10.1055/s-0044-1786687
Impact of Delta Troponin on Short-Term Mortality in Patients with Chronic Renal Dysfunction and NSTEMI
Funding and Sponsorship None.

Abstract
Introduction The relationship between mortality and troponin in non-ST-elevation myocardial infarction (NSTEMI) patients with a history of renal failure is quite limited. This study investigated the relationship between blood delta troponin T levels and 30-day mortality in patients with chronic renal dysfunction and NSTEMI.
Materials and Methods This study was conducted prospectively by including patients with chronic renal dysfunction and clinical findings of NSTEMI between February 1, 2021, and August 1, 2022. Demographics, medical history, laboratory parameters, and mortality data were noted. Thirty-day morbidity data was used for mortality. Delta troponin T was calculated using initial and first-hour troponin T values. Patients were grouped as healthy and deceased. Data were evaluated using univariant analysis and receiver operating characteristics analysis.
Results Of the 73 patients included in the study, 29 were female. The mean age of the patients was 67.3 years. The 30-day mortality rate was 9.5%. The sensitivity of the initial troponin T value was 85.7% (42.1–99.6), the specificity was 68.2% (55.6–79.1), and the accuracy was 69.9% (58–80.1), and the sensitivity of the first-hour troponin T value was 85.7% (42.1–99.6), specificity was 75.8% (63.6–85.5), and accuracy was 76.7% (65.4–85.8). The delta troponin T median of the mortality group was 56 (24.2–286.4), and the delta troponin median of the surviving patients was 29.4 (10.7–79.6). The difference was not statistically significant (p = 0.072).
Conclusion The current study's results show that delta troponin T (initial and first hour) is not associated with short-term mortality in patients with chronic renal dysfunction and NSTEMI.
Authors' Contributions
All authors contributed to collecting the data, writing the article, reviewing, and approving the final article, and they all took responsibility for its contents.
Compliance with Ethical Principles
The study was approved by the ethics committee of the University of Health Sciences Ümraniye Training and Research Hospital (date 02/11/2021; No: B.10.1.TKH.4.34.H.GP.0.01). Informed consent was obtained from all participants who have signed a general consent form allowing anonymous use of data for education, research, and quality improvement.
Publication History
Article published online:
11 July 2024
© 2024. The Libyan Biotechnology Research Center. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Özkan A, Sönmez E, Özdemir S. et al. The diagnostic value of SCUBE-1 in unstable angina pectoris patients. Eurasian J Emerg Med. 2016; 15 (04) 167-171
- 2 Amsterdam EA, Wenger NK. American College of Cardiology, American Heart Association. The 2014 American College of Cardiology ACC/American Heart Association guideline for the management of patients with non-ST-elevation acute coronary syndromes: ten contemporary recommendations to aid clinicians in optimizing patient outcomes. Clin Cardiol 2015; 38 (02) 121-123
- 3 Sachdeva P, Kaur K, Fatima S. et al. Advancements in myocardial infarction management: exploring novel approaches and strategies. Cureus 2023; 15 (09) e45578
- 4 Sonmez E, Turkdogan KA, Karabacak M. et al. The diagnostic role of signal peptide-C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein 1 in non-ST-elevation acute coronary syndrome. Am J Emerg Med 2015; 33 (01) 21-24
- 5 Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137 (07) 555-562
- 6 Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walford G, McCallister BD. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000; 36 (04) 1194-1201
- 7 Özkan A, Özdemir S. The new biomarkers for acute coronary syndrome. . Eurasian J. Crit Care 2023; 5 (02) 63-64
- 8 Algın A, Özdemir S. Comparison of the monocyte-to-HDL cholesterol ratio between patients with STEMI and NSTEMI: a retrospective observational study. J Clin Med Kaz. 2021; 18 (06) 45-49
- 9 Ziebig R, Lun A, Hocher B. et al. Renal elimination of troponin T and troponin I. Clin Chem 2003; 49 (07) 1191-1193
- 10 Lackner KJ. Cardiac troponins - a paradigm for diagnostic biomarker identification and development. Clin Chem Lab Med 2022; 61 (05) 795-800
- 11 Muslimovic A, Fridén V, Tenstad O. et al. The liver and kidneys mediate clearance of cardiac troponin in the rat. Sci Rep 2020; 10 (01) 6791
- 12 Fridén V, Starnberg K, Muslimovic A. et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem 2017; 50 (09) 468-474
- 13 Dubin RF, Li Y, He J. et al; CRIC Study Investigators. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol 2013; 14: 229
- 14 Wilhelm J, Hettwer S, Schuermann M. et al. Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications. Clin Res Cardiol 2014; 103 (07) 561-567
- 15 Røsjø H, Varpula M, Hagve TA. et al; FINNSEPSIS Study Group. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011; 37 (01) 77-85
- 16 Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem 1999; 45 (12) 2129-2135
- 17 Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 2000; 46 (03) 338-344
- 18 Ali SA, Kazmi S, Jalal-Ud-Din M, Qasim MI, Jadoon ZG. Frequency of elevated troponin T in patients of chronic renal failure without clinically suspected acute myocardial infarction. J Ayub Med Coll Abbottabad 2019; 31 (03) 364-367
- 19 Beattie JN, Soman SS, Sandberg KR. et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37 (06) 1191-1200
- 20 Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112 (20) 3088-3096
- 21 Aimo A, Januzzi Jr JL, Vergaro G. et al. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol 2019; 277: 166-172